Komori
COSMOS Pharmaceutical (3349) · InitiativeAchieved

Improving Share Liquidity and Broadening the Investor Base Through a Stock Split

First written in FY2020-Q3. 2 of 4 entries say "Achieved", first in FY2020. Latest entry: FY2025-H1.

4entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAchievedFY2020 – FY2025-H12020: 220202021: 020212022: 020222023: 020232024: 120242025: 1
Same theme, other companies
Stock SplitsA theme 934 companies write about · 0 as a headwind · 923 as a tailwind

116 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 946 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1AchievedAnnual report

    「Effective 1 September 2024, the company conducted a stock split at a ratio of 2 shares for every 1 common share.」

    The stock split resolved in FY2024 was implemented effective 1 September 2024, bringing the total number of issued shares to 80,001,600.
  2. FY2024AdvancedAnnual report

    「At a meeting of the Board of Directors held on 12 July 2024, the company resolved to issue new shares through a stock split and partially amend its Articles of Incorporation in connection with the stock split. The details of the stock split and partial amendment to the Articles of Incorporation are as follows.」

    The company resolved to implement a 1-for-2 stock split effective 1 September 2024, with the objectives of lowering the investment unit, improving liquidity and broadening the investor base.
  3. FY2020AchievedAnnual report

    「Based on a resolution of the Board of Directors meeting held on 13 April 2020, the Company conducted a share split and partially amended its Articles of Incorporation in connection with the share split, effective 1 June 2020.」

    Effective 1 June 2020, the company split each share into 2 shares, bringing the total number of issued shares to 40,000,800. The stated objectives were to lower the investment unit, improve share liquidity and broaden the investor base.
  4. FY2020-Q3First statedAnnual report

    「At a Board of Directors meeting held on 13 April 2020, the company resolved to conduct a stock split. The purpose was to improve the liquidity of the company’s shares and further expand its investor base. With 31 May 2020 as the record date, common shares held by shareholders recorded in the final shareholder register on that date were split at a ratio of 1 share to 2. The effective date was 1 June 2020.」

    The company resolved to split each share into 2 shares to improve liquidity and expand its investor base, with 31 May 2020 as the record date and 1 June 2020 as the effective date.
Moved together

"Further Growth Through Proactive Store Expansion" moved the same way as this thread, in the same document, in 3 of its 4 moves.

33332★12345
  1. ★This thread
  2. 1Further Growth Through Proactive Store Expansion3×
  3. 2Achieving a Dominant Share in Western Japan3×
  4. 3New Store Openings and Expansion of the Store Network3×
  5. 4Continued Capital Investment in New Stores3×
  6. 5Small-Catchment Mega Drugstore Model2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for COSMOS Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.